about
Current stage in inflammatory bowel disease: What is next?Pharmacologic therapy for inflammatory bowel disease refractory to steroidsStem cell therapy in inflammatory bowel disease: A promising therapeutic strategy?Biologic therapies for chronic inflammatory bowel disease.Therapy with stem cells in inflammatory bowel diseaseInfliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative Colitis.Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.Budd-Chiari syndrome associated with nodular regenerative hyperplasia of the liver[Systemic manifestations in primary biliary cirrhosis]Ustekinumab is effective and safe in the treatment of Crohn's disease refractory to anti-TNFα in an orthotopic liver transplant patient
P50
Q26777429-ADC116E0-B459-44C4-B46B-E491AA1FF34FQ26796415-2CE3786E-916D-46A7-B4BF-0CBC39F08AAFQ27022380-8ABCD8CA-D6F2-4DD4-B5DD-4272EC527F8DQ36515310-0361E6DC-C072-4135-B60F-C5F8F1B23982Q38191582-7579DBA0-C4D8-4F80-B6B5-654F8B5E7199Q40868226-549BA220-B101-457B-8F93-4AB9F40FBE68Q48904882-1D2CB1B9-D322-4626-8576-59BB19B5CE4FQ69555277-AFC6E340-2AAC-4000-A797-F246185C14B2Q69624797-927D3AC5-B53B-415E-8222-7AA63BE39320Q85371515-B96EBC9E-D8E3-44D0-92E3-0DAC99066803
P50
description
researcher
@en
wetenschapper
@nl
name
M P Martinez-Montiel
@ast
M P Martinez-Montiel
@en
M P Martinez-Montiel
@nl
type
label
M P Martinez-Montiel
@ast
M P Martinez-Montiel
@en
M P Martinez-Montiel
@nl
prefLabel
M P Martinez-Montiel
@ast
M P Martinez-Montiel
@en
M P Martinez-Montiel
@nl
P106
P31
P496
0000-0002-8688-8244